Historical Stock Price
ETFs Holding KBIO »    KBIO Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
07/31/2017 $1.60 $1.75 $1.60 $1.74 7.60K
08/01/2017 $1.60 $1.72 $1.60 $1.60 7.40K
08/02/2017 $1.59 $1.72 $1.57 $1.72 10.30K
08/03/2017 $1.61 $1.75 $1.61 $1.73 23.10K
08/04/2017 $1.60 $2.20 $1.60 $2.19 30.00K
Kalobios Pharmaceuticals is a biopharmaceutical company focused on the development of monoclonal antibody therapeutics. Using Co.'s Humaneered® antibody technology, Co. has produced a portfolio of antibodies to treat medical conditions with a primary clinical focus on respiratory diseases and cancer. Co. has developed three monoclonal antibodies to the clinical development stage: KB004, which is a Humaneered® anti-EphA3 monoclonal antibody; KB003, which is a Humaneered® anti-granulocyte macrophage colony-stimulating factor monoclonal antibody; and KB001-A, which is a Humaneered® developed for the prevention and treatment of Pseudomonas aeruginosa infections.
KBIO historical stock prices picture
KBIO (KBIO) has the following price history information. Looking back at KBIO historical stock prices for the last five trading days, on July 31, 2017, KBIO opened at $1.60, traded as high as $1.75 and as low as $1.60, and closed at $1.74. Trading volume was a total of 7.60K shares. On August 01, 2017, KBIO opened at $1.60, traded as high as $1.72 and as low as $1.60, and closed at $1.60. Trading volume was a total of 7.40K shares. On August 02, 2017, KBIO opened at $1.59, traded as high as $1.72 and as low as $1.57, and closed at $1.72. Trading volume was a total of 10.30K shares. On August 03, 2017, KBIO opened at $1.61, traded as high as $1.75 and as low as $1.61, and closed at $1.73. Trading volume was a total of 23.10K shares. On August 04, 2017, KBIO opened at $1.60, traded as high as $2.20 and as low as $1.60, and closed at $2.19. Trading volume was a total of 30.00K shares.

KBIO Historical Stock Prices By Date:

KBIO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into KBIO shares, starting with a $10,000 purchase of KBIO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/31/2013
End date: 08/04/2017
Start price/share: $64.00
End price/share: $2.19
Dividends collected/share: $0.00
Total return: -96.58%
Average Annual Total Return: -52.71%
Starting investment: $10,000.00
Ending investment: $342.16
Years: 4.51
Date Close
07/31/2017$1.74
08/01/2017$1.60
08/02/2017$1.72
08/03/2017$1.73
08/04/2017$2.19
KBIO is categorized under the Healthcare sector; below are some other companies in the same sector:

KBLM Historical Stock Prices
KDMN Historical Stock Prices
KEQU Historical Stock Prices
KERX Historical Stock Prices
KIDS Historical Stock Prices
KIN Historical Stock Prices
KIPS Historical Stock Prices
KITE Historical Stock Prices
KMPH Historical Stock Prices
KND Historical Stock Prices

KBIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.